Home > Insider Trading > Filing (0001104659-12-047033)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
881524	Vivus Inc	VVUS	Pharmaceutical Preparations (2834)	943136179

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1236514	Patrick Michael Miller	1172 Castro Street Mountain View CA 94040	Chief Commercial Officer	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2012-06-27	25,000	$10.19	32,943	No	4	M	Direct
Common Stock	Disposition	2012-06-27	25,000	$28.08	7,943	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Non-Qualified Stock Option (right to buy)	Disposition	2012-06-27	25,000	$0.00	25,000	$10.19

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
350,000		2020-04-30	No	4	M	Direct

Footnotes

The sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 12, 2012.
The sale price reported in column 4 of Table I represents the weighted average sale price of the shares sold ranging from $28.00 to $28.38 per share. Upon request by the Commission staff, the Issuer, or a sercurity holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price.
100,000 shares became exercisable on 4/26/2011 and the remaining 300,000 shares become exercisable at the end of each month thereafter until the option is fully vested on 4/26/2014.